| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 1,057,000 | 1,091,000 | 1,166,000 | 1,481,000 | | Cost of Revenue | 518,000 | 561,000 | 577,000 | 651,000 | | | Gross Profit | 539,000 | 530,000 | 589,000 | 830,000 | | | Operating Expenses | | Research Development | 153,000 | 170,000 | 169,000 | 170,000 | | Selling General and Administrative | 387,000 | 407,000 | 396,000 | 408,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,000) | (47,000) | 24,000 | 252,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,000) | 12,000 | 26,000 | 38,000 | | Earnings Before Interest And Taxes | (20,000) | (35,000) | 50,000 | 290,000 | | Interest Expense | 21,000 | 23,000 | 23,000 | 33,000 | | Income Before Tax | (41,000) | (58,000) | 27,000 | 257,000 | | Income Tax Expense | (22,000) | 43,000 | (37,000) | 26,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,000) | (101,000) | 64,000 | 231,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,000) | (101,000) | 64,000 | 231,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,000) | ($101,000) | $64,000 | $231,000 |
|
0.51% Nasdaq 
Income Statement
